Kenneth R. Deans Jr.
Carolina del Sur
Kenneth R. Deans Jr. es colaborador de The American Quorum. Con más de 30 años de experiencia en puestos de liderazgo en los sectores de la salud, la tecnología y la educación, aporta una perspectiva independiente y basada en su amplia experiencia a los temas que marcan el rumbo de Estados Unidos.
Política
Nearly 2,000 Flights Canceled in a Single Day: Inside the Structural Collapse Behind America's Summer of Air Travel Chaos
Salud
The Hidden Data Layer of Caregiving: Integrating Informal and Formal Dementia Care into Health Systems
Reseñas de libros
El American Quorum busca reseñistas de libros voluntarios
Salud
Medicare Sets 2.3% Hospital Pay Raise for 2027, Adding $2.9 Billion as Nonprofits Outpace For-Profits
Salud
H5N1 Dairy-Cattle Outbreak Reaches 8 States as CDC Tracks First U.S. Human Case Linked to Infected Cows
Tecnología
Meta Releases Llama 3 in 8B and 70B Models, Trained on More Than 15 Trillion Tokens as Meta AI Expands Across Apps
Salud
CDC Warns Measles Resurgence Threatens U.S. Elimination Status as First-Quarter Cases Jump More Than 17-Fold
Tecnología
Google Unveils Axion Arm CPU and Expands AI Infrastructure as Cloud Providers Race to Build Their Own Silicon
Salud
Texas Dairy Worker Tests Positive for H5N1 as U.S. Confirms First Human Bird-Flu Case Linked to Infected Cattle
Tecnología
Microsoft Separates Teams From Office Worldwide as Antitrust Scrutiny Reshapes Its Enterprise Software Bundles
Salud
FDA Approves Winrevair for Pulmonary Arterial Hypertension After Trial Cuts Risk of Death or Clinical Worsening 84%
Tecnología
AT&T Says Dark-Web Data Set Affects 73 Million Current and Former Customers, Resets Millions of Passcodes
Salud
Massachusetts General Transplants Gene-Edited Pig Kidney Into Living Patient, a First for Xenotransplantation
Tecnología
Justice Department and 16 Attorneys General Sue Apple, Alleging iPhone Monopoly Maintained Through App, Messaging and Device Restrictions
Salud
FDA Approves Rezdiffra as First Drug for NASH With Moderate-to-Advanced Fibrosis After Phase 3 Biopsy Gains
Tecnología
European Parliament Backs AI Act 523-46, Advancing Risk-Based Rules for Generative Models and High-Risk Systems
Salud
FDA Expands Wegovy to Cardiovascular Risk Reduction After 17,604-Patient Trial Shows 20% Fewer Major Events
422 stories